Cardiovascular Drugs and Therapy

, Volume 19, Issue 3, pp 173–175 | Cite as

Cough with ACE Inhibitors: A Bigger Problem in Some Racial Groups?

  • M. Gary Nicholls
  • Nigel L. Gilchrist


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Reisin L, Schneeweiss A. Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril). Am J Cardiol 1992;70:398–399.CrossRefPubMedGoogle Scholar
  2. Lip GY, Zarifis J, Beevers M, Beevers DG. Duration of cough following cessation of ACE inhibitor therapy. Am J Hypertens 1995;8:98.CrossRefPubMedGoogle Scholar
  3. Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997;350: 15–18.CrossRefPubMedGoogle Scholar
  4. Umemura K, Nakashima M, Saruta T. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci 1997;60:1583–1588.CrossRefPubMedGoogle Scholar
  5. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough. Nat Med 1996;2:814–817.CrossRefPubMedGoogle Scholar
  6. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994;12:1387–1393.PubMedGoogle Scholar
  7. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998;352:1069.CrossRefGoogle Scholar
  8. Okaishi K, Morimoto S, Fukuo K, et al. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 1999;12:778–783.CrossRefPubMedGoogle Scholar
  9. Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens 2000;13:1050–1051.CrossRefPubMedGoogle Scholar
  10. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004;52:2010–2015.CrossRefPubMedGoogle Scholar
  11. Chan WK, Chan TYK, Luk WK, Leung VKS, Li TH, Critchley JAJH. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 1993;44:299–300.CrossRefPubMedGoogle Scholar
  12. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 1995;75:967–968.CrossRefPubMedGoogle Scholar
  13. Morimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004;10:499–509.CrossRefPubMedGoogle Scholar
  14. Morimoto T, Gandhi TK, Fiskio JM, et al. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J Gen Intern Med 2004;19:684–691.CrossRefPubMedGoogle Scholar
  15. Yeo WW, Foster G, Ramsay LE. Prevalence of persistent cough during long-term enalapril treatment: Controlled study versus nifedipine. Q J Med 1991;81:763–770.Google Scholar
  16. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994;7:1012–1015.PubMedGoogle Scholar
  17. Efstratopoulos AD, Meikopoulos M, Voyaki S. Frequency of cough during therapy with ACE inhibitors in Greek hypertensives. J Hum Hypertens 1993;7:607–609.PubMedGoogle Scholar
  18. Fisman EZ, Grossman E, Motro M, Tenenbaum A. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002;16:379–383.CrossRefPubMedGoogle Scholar
  19. Nicholls MG, Gilchrist NL. Sulindac and cough induced by converting enzyme inhibitors. Lancet 1987;1:872.Google Scholar
  20. Fuller RW. Cough associated with angiotensin-converting enzyme inhibitors. J Hum Hypertens 1989;3:159–161.PubMedGoogle Scholar
  21. Gilchrist NL, Richards AM, March R, Nicholls MG. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: Randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989;3:451–455.PubMedGoogle Scholar
  22. Fogari R, Zoppi A, Tettamanti F, Malamani GD, Tinelli C, Salvetti A. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: A double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992;19:670–673.PubMedGoogle Scholar
  23. Ohya Y, Kumamoto K, Fujishima M. Effects of crossover application of sulindac and azelastine on enalapril-induced cough. J Hum Hypertens 1992;6:81–82.PubMedGoogle Scholar
  24. Malini PL, Strocchi E, Fiumi N, Ambrosioni E, Ciavarella A. ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care 1999;22:1586–1587.PubMedGoogle Scholar
  25. Lee Y-J, Tsai JCR. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 2001;50:1346–1350.CrossRefPubMedGoogle Scholar
  26. Ogihara T, Mikami H, Katahira K, Otsuka A. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex. Am J Hypertens 1991;4:46S–51S.PubMedGoogle Scholar
  27. Sasaguri M, Ideishi M, Kinoshita A, Arakawa K. Differential inhibition of bradykinin hydrolysis by four ACE Inhibitors: A possible explanation for differences in induced coughing. Hypertens Res 1994;17:253–258.Google Scholar
  28. Yeo WW, Ramsay LE. Persistent dry cough with enalapril: Incidence depends on method used. J Hum Hypertens 1990;4:517–520.PubMedGoogle Scholar
  29. Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: How much of a problem? J Hypertens 1994;12(Suppl 2):S43–S47.Google Scholar
  30. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996;60:8–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • M. Gary Nicholls
    • 1
  • Nigel L. Gilchrist
    • 2
  1. 1.Department of Internal Medicine, Faculty of Medicine and Health SciencesUAE UniversityAl AinUnited Arab Emirates
  2. 2.Health Care of the ElderlyThe Princess Margaret HospitalChristchurchNew Zealand

Personalised recommendations